statistiche ricercatore

Continente	#
EU - Europa	961
NA - Nord America	918
AS - Asia	397
SA - Sud America	99
AF - Africa	9
Continente sconosciuto - Info sul continente non disponibili	9
Totale	2.393

Nazione	#
US - Stati Uniti d'America	901
RU - Federazione Russa	502
SG - Singapore	157
CN - Cina	135
IE - Irlanda	106
SE - Svezia	95
BR - Brasile	89
DE - Germania	58
GB - Regno Unito	46
UA - Ucraina	40
HK - Hong Kong	31
FI - Finlandia	30
VN - Vietnam	29
IT - Italia	26
FR - Francia	24
IN - India	20
BE - Belgio	15
CA - Canada	9
AR - Argentina	5
JP - Giappone	4
AE - Emirati Arabi Uniti	3
ES - Italia	3
KE - Kenya	3
MX - Messico	3
PL - Polonia	3
TN - Tunisia	3
AL - Albania	2
AT - Austria	2
CH - Svizzera	2
CO - Colombia	2
DK - Danimarca	2
EC - Ecuador	2
IQ - Iraq	2
IR - Iran	2
MA - Marocco	2
PK - Pakistan	2
TR - Turchia	2
UZ - Uzbekistan	2
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BG - Bulgaria	1
BO - Bolivia	1
BZ - Belize	1
CR - Costa Rica	1
CW - ???statistics.table.value.countryCode.CW???	1
CZ - Repubblica Ceca	1
EU - Europa	1
ID - Indonesia	1
JM - Giamaica	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LB - Libano	1
LK - Sri Lanka	1
NL - Olanda	1
NP - Nepal	1
PT - Portogallo	1
SV - El Salvador	1
TH - Thailandia	1
TT - Trinidad e Tobago	1
ZA - Sudafrica	1
Totale	2.386

Nome	#
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma	212
Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma?	207
High serum resistin in chronic viral hepatitis is not a marker of metabolic disorder.	204
Serum thrombopoietin in chronic liver disease: Relation to severity of the disease and spleen size	179
Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: Effect of treatment with recombinant alpha interferon	178
Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma.	172
Clinical improvement and serum amino acid levels after mud-bath therapy	161
HCV INFECTION, HEPATIC HLA DISPLAY AND COMPOSITION OF THE MONONUCLEAR CELL INFLAMMATORY INFILTRATE IN CHRONIC-ALCOHOLIC LIVER-DISEASE	156
Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up	155
Ten year follow-up of patients with chronic hepatitis C treated with interferon	152
[Behavior of anti-HBc IgM in acute and chronic hepatitis].	152
Cyclin A and E2F1 overexpression correlate with reduced disease-free survival in node-negative breast cancer patients	149
Markers of cell proliferation, apoptosis, and angiogenesis in thyroid adenomas: a comparative immunohistochemical and genetic investigation of functioning and nonfunctioning nodules	143
High Serum Resistin in Chronic Viral Hepatitis Is not a Marker of Metabolic Disorder	92
null	81
Totale	2.393

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	80	0	0	0	0	3	2	6	3	2	18	15	31
2022/2023	327	20	32	17	26	34	33	2	29	122	2	6	4
2023/2024	90	4	10	4	8	5	30	2	21	0	3	0	3
2024/2025	326	1	8	7	34	4	9	4	63	73	27	40	56
2025/2026	1.003	59	43	59	41	91	188	130	160	152	53	14	13
2026/2027	165	20	33	49	59	4	0	0	0	0	0	0	0
Totale													2.393